<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药事纵横 | wechat-feeds</title><link>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</link><description>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！ 投稿请发：442015666@qq.com 推广合作请联系：15057280775/15858667450</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 27 May 2021 07:36:04 +0800</pubDate><image><url>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</url><title>药事纵横 | wechat-feeds</title><link>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>二线CXO：何时突破500亿市值封锁</title><link>https://mp.weixin.qq.com/s/Wohsj7_VGq_hs2Ug3pSaWg</link><description></description><content:encoded><![CDATA[二线CXO：何时突破500亿市值封锁]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/jWoOIO0AfLW5ZS0LGW9Gzg</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/pZwK-RvSQULS2uzsY_h9Aw</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>2021.05.24药品批件信息！52个药品通过一致性评价</title><link>https://mp.weixin.qq.com/s/qyjem9PMYi3nlPf4sKVOZg</link><description></description><content:encoded><![CDATA[2021.05.24药品批件信息！52个药品通过一致性评价]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>“酶”好时代来临：数家药企角逐助力绿色制药</title><link>https://mp.weixin.qq.com/s/BRRlTDitsQifv3AMOtHQjg</link><description></description><content:encoded><![CDATA[“酶”好时代来临：数家药企角逐助力绿色制药]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>康龙化成&amp;凯莱英，千亿市值，两种战略</title><link>https://mp.weixin.qq.com/s/RZMZYfPYSlSRNxZ_T3GnRQ</link><description></description><content:encoded><![CDATA[康龙化成&凯莱英，千亿市值，两种战略]]></content:encoded><pubDate>Tue, 25 May 2021 16:05:56 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/mgPZNnmQY4B6Rrf4HqQPRA</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Tue, 25 May 2021 16:05:56 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/YOhd7WGmBSvL0vZLsVMAWw</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Tue, 25 May 2021 16:05:56 +0800</pubDate></item><item><title>58个创新药申请临床，6款新药获批！恒瑞、百济神州、绿叶制药...厚积薄发</title><link>https://mp.weixin.qq.com/s/jczxbc7W0ZMzcwgQYAUXGw</link><description></description><content:encoded><![CDATA[58个创新药申请临床，6款新药获批！恒瑞、百济神州、绿叶制药...厚积薄发]]></content:encoded><pubDate>Tue, 25 May 2021 16:05:56 +0800</pubDate></item><item><title>风云浙商，5人执掌药企超万亿市值</title><link>https://mp.weixin.qq.com/s/4Rw7qVYTFLJ1pVb9ztjtfA</link><description></description><content:encoded><![CDATA[风云浙商，5人执掌药企超万亿市值]]></content:encoded><pubDate>Tue, 25 May 2021 16:05:56 +0800</pubDate></item><item><title>阿达木单抗背后的技术：噬菌体展示技术</title><link>https://mp.weixin.qq.com/s/55-5uC0gw3sN8q4J9C1LNA</link><description></description><content:encoded><![CDATA[阿达木单抗背后的技术：噬菌体展示技术]]></content:encoded><pubDate>Mon, 24 May 2021 09:32:38 +0800</pubDate></item><item><title>液相故障排除指南(九)：梯度法的传递</title><link>https://mp.weixin.qq.com/s/1B87F2WuPfYA8XtPaaciIw</link><description></description><content:encoded><![CDATA[液相故障排除指南(九)：梯度法的传递]]></content:encoded><pubDate>Mon, 24 May 2021 09:32:38 +0800</pubDate></item><item><title>观察：短缺药与虚高价，如何权衡？</title><link>https://mp.weixin.qq.com/s/cH3XnX3vMCSasRLasZlAHw</link><description></description><content:encoded><![CDATA[观察：短缺药与虚高价，如何权衡？]]></content:encoded><pubDate>Mon, 24 May 2021 09:32:38 +0800</pubDate></item><item><title>压片工艺必知的那些事儿</title><link>https://mp.weixin.qq.com/s/vpalUuV32A0nPaK8Wn_3ig</link><description></description><content:encoded><![CDATA[压片工艺必知的那些事儿]]></content:encoded><pubDate>Mon, 24 May 2021 09:18:18 +0800</pubDate></item><item><title>液相故障排除指南(八)：系统——体积死体积, 柱体积</title><link>https://mp.weixin.qq.com/s/nfoHCsjOByqoKVet75gXgw</link><description></description><content:encoded><![CDATA[液相故障排除指南(八)：系统——体积死体积, 柱体积]]></content:encoded><pubDate>Mon, 24 May 2021 09:18:18 +0800</pubDate></item><item><title>从国家第四批药品集采，看到切实成长、基本定型</title><link>https://mp.weixin.qq.com/s/1fc-C6DFIcM6KMlV_HZJOQ</link><description></description><content:encoded><![CDATA[从国家第四批药品集采，看到切实成长、基本定型]]></content:encoded><pubDate>Mon, 24 May 2021 09:18:18 +0800</pubDate></item><item><title>隐秘角落：除了Big Pharma和Biotech，另一只创新力量正崛起</title><link>https://mp.weixin.qq.com/s/0xDQaix4HlMY29odQzmNlg</link><description></description><content:encoded><![CDATA[隐秘角落：除了Big Pharma和Biotech，另一只创新力量正崛起]]></content:encoded><pubDate>Sat, 22 May 2021 21:18:46 +0800</pubDate></item><item><title>ACGT China是什么？我为什么推荐给你</title><link>https://mp.weixin.qq.com/s/uJzkIYxOoR0V8JByFebO0Q</link><description></description><content:encoded><![CDATA[ACGT China是什么？我为什么推荐给你]]></content:encoded><pubDate>Sat, 22 May 2021 21:18:46 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/hbVI7GtnWna2u1DQEHwsOg</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Sat, 22 May 2021 21:18:46 +0800</pubDate></item><item><title>做药必看！CDE正式发布《中国上市药品专利信息登记平台》，测试时间至5月31日</title><link>https://mp.weixin.qq.com/s/aiXeOT8GxVpbfpznMjliCQ</link><description></description><content:encoded><![CDATA[做药必看！CDE正式发布《中国上市药品专利信息登记平台》，测试时间至5月31日]]></content:encoded><pubDate>Sat, 22 May 2021 21:18:46 +0800</pubDate></item></channel></rss>